摘要
目的:应用化学交换敏感自旋锁(CESL)磁共振成像技术,研究阿尔茨海默病(AD)模型小鼠脑Aβ蛋白的可交换质子信号。方法:选用8只未转基因小鼠(5只幼龄,3只)和12只TG-APPswe/PSdE 9小鼠(5只幼龄,7只)。ω1=25 Hz,TSL=3.0s,ω1=5 0Hz,TSL=15 0ms,在Ω=7.0ppm的偏移频率不均匀的情况下,在9.4-T动物MRI系统中获得CESLZ-谱。在Z谱分析中,感兴趣区(ROIS)被绘制在两个半球的皮层、海马和丘脑。由Z谱得到了磁化强度传递比不对称(MTRasym)曲线。用Mann-Whitney试验比较TG和非TG小鼠在每一偏移频率和每一ROI上的MTRasym值。结果:饱和功率为25 Hz时,全Z谱的水饱和度宽度较窄,而在500 Hz饱和功率下,水饱和度宽度相对较宽。在25 Hz CESL饱和功率下,大多数MTRasym值在3.5、3.0、2.0和0.9ppm偏移频率下为负值,仅在3.5ppm偏置时,对照组与TG组间MTRasym值有显着性差异(p=0.0487)。MTRasym值分别为-6%~-7%(3.5和3.0 ppm),而2.0和0.9ppm的MTRasym值均小于-2%。在500 Hz CESL饱和功率下,所有MTRasym值在3.5-、3.0-、2.0-和0.9-ppm偏移频率上均为正,MTRasym值在所有ROIS和所有偏移频率上,对照组与TG组之间无显着性差异。然而,在3.5ppm时,对照组与TG组在右侧皮质有显著差异(p=0.0578)。MTRasym值3.5、3.0和2.0ppm时为6%~9%,0.9ppm时MTRasym值小于2%。结论:在体内AD模型实验中,MTRasym值随饱和功率的增加而增加。MTRasym值除左侧丘脑区3.5ppm偏移外,差异无显着性(P>0.05)。CESL技术应进一步发展,使其在神经退行性疾病患者的大脑中得到应用。
关键词: 磁共振成像,可交换质子信号,淀粉样β(Aβ)蛋白,阿尔茨海默病,淀粉样斑块。
Current Alzheimer Research
Title:Mapping Exchangeable Protons to Monitor Protein Alterations in the Brain of an Alzheimer’s Disease Mouse Model by Using MRI
Volume: 15 Issue: 14
关键词: 磁共振成像,可交换质子信号,淀粉样β(Aβ)蛋白,阿尔茨海默病,淀粉样斑块。
摘要: Objective: The study aimed to investigate exchangeable proton signals of Aβ proteins of the brains of Alzheimer’s disease (AD) model mice by using a chemical exchange-sensitive spin-lock (CESL) MR imaging technique.
Method: Eight non-transgenic (Tg) mice (5 young and 3 old) and twelve Tg-APPswe/PSdE9 mice (5 young and 7 old) were used in this study. CESL Z-spectra were obtained by using two saturation powers, which were ω1 = 25 Hz with TSL = 3.0 s and ω1 = 500 Hz with TSL = 150 ms, at 71 offsets with uneven intervals between the offset frequencies at Ω = ±7.0 ppm at a 9.4-T animal MRI system. For Zspectrum analyses, regions of interest (ROIs) were drawn in the cortex, hippocampus, and thalamus of both hemispheres. Magnetization transfer ratio asymmetry (MTRasym) curves were obtained from the Zspectra. The Mann-Whitney test was used to compare the MTRasym values between the Tg and non-Tg mice for each offset frequency and for each ROI.
Results: The water saturation width of the full Z-spectrum was narrow with the 25-Hz saturation power, but relatively broad with the 500-Hz saturation power. With the 25-Hz CESL saturation power, most of the MTRasym values were negative for 3.5-, 3.0-, 2.0-, and 0.9-ppm offset frequencies and the MTRasym values were significantly different between the control and Tg groups only in the left thalamus region at 3.5 ppm offset (p=0.0487). The MTRasym values were -6% to -7% for both 3.5 and 3.0 ppm, but less than -2% for both 2.0 and 0.9 ppm. With 500-Hz CESL saturation power, all the MTRasym values were positive for the 3.5-, 3.0-, 2.0-, and 0.9-ppm offset frequencies and the MTRasym values were not significantly different between the control and Tg groups at all ROIs and at all offset frequencies. However, a trend towards a significant difference was observed between the control and Tg groups in the right cortex at 3.5 ppm (p=0.0578). The MTRasym values were 6% to 9% for 3.5, 3.0, and 2.0 ppm, but less than 2% for 0.9 ppm.
Conclusion: In an in-vivo AD model experiment, MTRasym values increased with the high saturation power than with the low saturation power. The MTRasym values were not significantly different, except in the left thalamus region at 3.5 ppm offset. The CESL technique should be further developed to enable its application in the brain of patients with neurodegenerative diseases.
Export Options
About this article
Cite this article as:
Mapping Exchangeable Protons to Monitor Protein Alterations in the Brain of an Alzheimer’s Disease Mouse Model by Using MRI, Current Alzheimer Research 2018; 15 (14) . https://dx.doi.org/10.2174/1567205015666180911143518
DOI https://dx.doi.org/10.2174/1567205015666180911143518 |
Print ISSN 1567-2050 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5828 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
The Basic Biology of BACE1: A Key Therapeutic Target for Alzheimers Disease
Current Genomics The Trigeminocardiac Reflex as Oxygen Conserving Reflex in Humans: Its Ischemic Tolerance Potential
Vascular Disease Prevention (Discontinued) An Anti-apoE4 Specific Monoclonal Antibody Counteracts the Pathological Effects of apoE4 In Vivo
Current Alzheimer Research Sugars that Glow in the Dark: Fluorescent Tagged Glucose Bioprobes and their Facilitation of the Drug Discovery Process
Current Medicinal Chemistry Green Synthesis of Phosphoryl-2-Oxo-2H-Pyran via Three Component Reaction of Trialkyl Phosphites
Combinatorial Chemistry & High Throughput Screening Editorial (Hot Topic: Neuroprotection and Neuroregeneration in Ischemic Stroke: Emerging Treatment Strategies and Potential Molecular Targets)
Current Drug Targets Anesthesia Issues in Central Nervous System Disorders
Current Aging Science Sialic Acid and the Central Nervous System: Perspectives on Biological Functions, Detection, Imaging Methods and Manipulation
CNS & Neurological Disorders - Drug Targets Dual BACE-1/GSK-3β Inhibitors to Combat Alzheimer's Disease: A Focused Review
Current Topics in Medicinal Chemistry Reduction of Aβ Levels in the Sprague Dawley Rat After Oral Administration of the Functional g-Secretase Inhibitor, DAPT: A Novel Non- Transgenic Model for Aβ Production Inhibitors
Current Pharmaceutical Design Military Risk Factors for Cognitive Decline, Dementia and Alzheimer’s Disease
Current Alzheimer Research Antioxidant Capacities of Flavones and Benefits in Oxidative-Stress Related Diseases
Current Topics in Medicinal Chemistry miR-132 Down-regulates Methyl CpG Binding Protein 2 (MeCP2) During Cognitive Dysfunction Following Chronic Cerebral Hypoperfusion
Current Neurovascular Research Recent Developments in Deception Research
Current Psychiatry Reviews Cholesterol Homeostasis Failure in the Brain: Implications for Synaptic Dysfunction and Cognitive Decline
Current Medicinal Chemistry η-Secretase: Reduction of Amyloid Precursor Protein η-Site Cleavage in Alzheimers Disease
Current Alzheimer Research Triglyceride Level Affecting Shared Susceptibility Genes in Metabolic Syndrome and Coronary Artery Disease
Current Medicinal Chemistry Special Invited Article Concussion, Sports and Psychiatry
Adolescent Psychiatry Caring for HIV-Infected Patients in the ICU in The Highly Active Antiretroviral Therapy Era
Current HIV Research Exogenous Progesterone: A Potential Therapeutic Candidate in CNS Injury and Neurodegeneration
Current Medicinal Chemistry